These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3. Holmes JA; Congiu M; Bonanzinga S; Sandhu MK; Kia YH; Bell SJ; Nguyen T; Iser DM; Visvanathan K; Sievert W; Bowden DS; Desmond PV; Thompson AJ Aliment Pharmacol Ther; 2015 Aug; 42(3):296-306. PubMed ID: 26032235 [TBL] [Abstract][Full Text] [Related]
6. Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus. Aka PV; Kuniholm MH; Pfeiffer RM; Wang AS; Tang W; Chen S; Astemborski J; Plankey M; Villacres MC; Peters MG; Desai S; Seaberg EC; Edlin BR; Strickler HD; Thomas DL; Prokunina-Olsson L; Sharp GB; O'Brien TR J Infect Dis; 2014 Feb; 209(3):350-4. PubMed ID: 23956438 [TBL] [Abstract][Full Text] [Related]
7. Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians. Knapp S; Zakaria Z; Hashem M; Zaghla H; Khakoo SI; Waked I; Thursz M; Abdelwahab SF Hepatol Int; 2015 Apr; 9(2):251-7. PubMed ID: 25788203 [TBL] [Abstract][Full Text] [Related]
8. Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes. Lang Kuhs KA; Kuniholm MH; Pfeiffer RM; Chen S; Desai S; Edlin BR; Peters MG; Plankey M; Sharp GB; Strickler HD; Villacres MC; Quinn TC; Gange SJ; Prokunina-Olsson L; Greenblatt RM; O'Brien TR PLoS One; 2015; 10(10):e0138827. PubMed ID: 26431156 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. Stättermayer AF; Strassl R; Maieron A; Rutter K; Stauber R; Strasser M; Beinhardt S; Datz C; Scherzer TM; Steindl-Munda P; Gschwantler M; Trauner M; Hofer H; Ferenci P Aliment Pharmacol Ther; 2014 Jan; 39(1):104-11. PubMed ID: 24205831 [TBL] [Abstract][Full Text] [Related]
11. Association of interferon lambda-4 rs12979860 polymorphism with hepatocellular carcinoma in patients with chronic hepatitis C infection. de Bitencorte JT; Rech TF; Lunge VR; Dos Santos DC; Álvares-da-Silva MR; Simon D World J Hepatol; 2021 Jan; 13(1):109-119. PubMed ID: 33584990 [TBL] [Abstract][Full Text] [Related]
12. Interferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-Analysis. Wu Q; Wang C; Chen EQ; Tang H; Li ZZ; Lei XZ Hepat Mon; 2015 Dec; 15(12):e32707. PubMed ID: 26977165 [TBL] [Abstract][Full Text] [Related]
13. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant. Konishi H; Motomura T; Matsumoto Y; Harimoto N; Ikegami T; Yoshizumi T; Soejima Y; Shirabe K; Fukuhara T; Maehara Y J Viral Hepat; 2014 Jun; 21(6):397-404. PubMed ID: 24750545 [TBL] [Abstract][Full Text] [Related]
14. The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study. Sharafi H; Alavian SM; Behnava B; Pouryasin A; Keshvari M Hepat Mon; 2014 Oct; 14(10):e22649. PubMed ID: 25419220 [TBL] [Abstract][Full Text] [Related]
15. Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A. Akamatsu S; Hayes CN; Ochi H; Uchida T; Kan H; Murakami E; Abe H; Tsuge M; Miki D; Akiyama R; Hiraga N; Imamura M; Aikata H; Kawaoka T; Kawakami Y; Chayama K J Hepatol; 2015 Sep; 63(3):554-63. PubMed ID: 25849245 [TBL] [Abstract][Full Text] [Related]
16. IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6. Akkarathamrongsin S; Thong VD; Payungporn S; Poovorawan K; Prapunwattana P; Poovorawan Y; Tangkijvanich P J Med Virol; 2014 Sep; 86(9):1482-90. PubMed ID: 24782280 [TBL] [Abstract][Full Text] [Related]
17. A Simple PCR-RFLP Method for Genotyping of IFNL4 rs368234815 Polymorphism in Patients With Chronic Hepatitis C. Pouryasin M; Sharafi H; Behnava B; Alavian SM; Keshvari M; Pouryasin A Lab Med; 2017 Feb; 48(1):51-56. PubMed ID: 28057801 [TBL] [Abstract][Full Text] [Related]
18. Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection. Waldenström J; Kåberg M; Alanko Blomé M; Widell A; Björkman P; Nilsson S; Hammarberg A; Weiland O; Nyström K; Lagging M Scand J Gastroenterol; 2021 Jul; 56(7):855-861. PubMed ID: 34034600 [TBL] [Abstract][Full Text] [Related]
19. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients. Galmozzi E; Facchetti F; Grossi G; Loglio A; Viganò M; Lunghi G; Colombo M; Lampertico P Liver Int; 2018 Mar; 38(3):417-423. PubMed ID: 28732143 [TBL] [Abstract][Full Text] [Related]
20. Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples. Amanzada A; Kopp W; Spengler U; Ramadori G; Mihm S PLoS One; 2013; 8(12):e84026. PubMed ID: 24376784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]